Possible Effects of Ibuprofen Pretreatment on Seizure Duration During Electroconvulsive Therapy
J Clin Psychiatry 2004;65:442[letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not
have an abstract, we have provided for your benefit the first 3 sentences
of the full text.
Leung and colleagues1 recently reported on the pretreatment
of patients undergoing electroconvulsive therapy (ECT)
with ibuprofen in an apparently successful attempt at reducing
the incidence of post-ECT headache. One of the more interesting
findings from their data, however, goes unmentioned in
their discussion of the otherwise useful study. Table 1(p552)
their article compares the placebo group and the ibuprofen
group on a number of factors, one of which is seizure duration.